Home Lentigen

Lentigen

acquired
-
Biotechnology Pharmaceutical Company
Basic
Enterprise Profile

Basic Information

Lentigen Corporation is a biotechnology company engaged in the development and commercialization of gene delivery technologies for human diseases. It provides lentiviral vector technology for a range of therapeutic, vaccine, and research applications in the biotechnology and medical fields.
Lentigen Corporation
Maryland,United States of America
15~50 people
January 01, 2005
macs@miltenyibiotec.de

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production Vaccine Formulation Production
Technology
Gene Technology Cell Technology Protein Technology
Concept
Tumor Hematologic Diseases Chronic Disease Therapeutic Products
Application Scenarios
Biologics Biological Products